Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e12567
Abstract: e12567Background: Eribulin is licensed for the ≥2-line treatment of patients with metastatic breast cancer. We assessed outcome of eribulin treatment in real world patients. Methods: We conducted a retrospective analysis of consecutive patients treated with…
read more here.
Keywords:
patients metastatic;
breast cancer;
metastatic breast;
treated eribulin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "European Journal of Dermatology"
DOI: 10.1684/ejd.2018.3278
Abstract: Different pathways have been proposed to explain the apoptotic effects of local anaesthetics, such as extracellular signalling-regulated mitogen-activated protein kinase and protein kinase B-mediated processes [9, 10]. Earlier reports from our team have shown that…
read more here.
Keywords:
case cutaneous;
angiosarcoma successfully;
cutaneous angiosarcoma;
treated eribulin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "In Vivo"
DOI: 10.21873/invivo.12903
Abstract: Aim: To examine the role of the Modified Glasgow Prognostic Score (mGPS) and Prognostic Nutritional Index (PNI) as prognostic markers for patients with metastatic breast cancer (MBC). Patients and Methods: We investigated the associations of…
read more here.
Keywords:
modified glasgow;
prognostic nutritional;
treated eribulin;
glasgow prognostic ... See more keywords